Atlas Trials

Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging

Clinical trial NCT04273555 · WITHDRAWN

Trial details

NCT number
NCT04273555
Sponsor
University of Alabama at Birmingham
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
HER2-positive Breast Cancer
Start date
2026-03-01
Primary completion
2028-06-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.